The total market for animal therapeutics and diagnostics was $30 billion in
2011, up from $25 billion in 2008. By 2016, this market is likely to exceed
$42 billion, with a five-year compound annual growth rate (CAGR) of 7.2% from
2011 through 2016.
The pharmaceutical segment accounts for the largest percentage of revenue with
nearly 48%. Sales for this segment reached $14.3 billion in 2011 and are
expected to increase to nearly $21.0 billion by 2016, a CAGR of 7.5%.
Feed additives represent the second-largest market segment, with a total
market value of $8.3 billion in 2011. This segment is forecast to grow at a
CAGR of 5% during the next five years and reach $10.6 billion by 2016.
REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This BCC Research report, Global Markets for Animal Therapeutics and
Diagnostics, provides an overview of products included in this market and
detailed market analyses and competitive environments. The study includes
information about significant products, players, issues and trends, and other
information affecting the animal therapeutic and diagnostic market.
REASONS FOR DOING THE STUDY
The animal health industry is responsible for maintaining the health and
productivity of the over 3.3 billion livestock and 16 billion poultry
worldwide and ensuring the wholesomeness and abundance of the food they
produce. In addition, the industry must also cater to the health and well
being of companion animals. Despite this, the human healthcare market is 35
times larger than the combined market for all nonhuman species. The reality
is that the global animal health market is very complex, operating under
stringent and increasingly strict regulations similar to those for human
health, yet the market opportunities are considerably smaller. In an
increasingly risky environment for new product development, the difference
between success and failure in the future usually lies in successfully
identifying the next growth segment, developing the right product candidates
and being the first to market. Despite all these risks, the industry
continues to grow.
In contrast to human blockbuster-oriented pharmaceuticals, animal health is
dominated by large numbers of products with small revenues. Although there
are hundreds of products involved in this market, only about 30 products have
sales exceeding $100 million per year. However, the industry continues to
forge on. The fastest growing therapeutic categories are in the area of
companion animals, specifically in the arthritis and pain segments of the
market.
A challenging aspect of the market is within the animal food industry as
consumers continue to express concern about the conditions under which their
daily food is produced. Consumers are becoming more health conscious and
demanding healthy and balanced diets. By implementing a feeding plan that
provides vitamins and supplements, consumers enjoy additional nutritional
benefits. Additionally, healthy feeding results in minimized impact on the
environment.
INTENDED AUDIENCE
The information within this report is directed at the business and industry
professional and is specifically designed to aid in the explanation, direction
and future of animal health markets. The report focuses on providing the
reader with an understanding of trends in the industry, market segments,
market forecasts, leading players, market drivers and inhibitors.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that will
provide a thorough evaluation of the animal therapeutic and diagnostic market.
The geographical scope of this study is worldwide, with special interest for
markets, trends and statistics by key geographical regions such as the United
States, European countries and Brazil, Japan and Australia. The report
identifies markets in four segments: vaccines, pharmaceuticals, feed additives
and diagnostics. For the purpose of this study, diagnostics includes products
that are used at the point of care and are considered rapid tests or kits.
Each market segment provides detailed information based on product categories,
use of products, forecasts and competitive analyses.
INFORMATION SOURCES
The information for this BCC report was obtained through primary and secondary
data-collection methods. Primary methods included interviews with
approximately 40 key executives, product managers and clinical specialists
involved in the animal health industry. Secondary methods included published
literature in the area of animal science and veterinary services, investment
reports, company literature, and various animal health journals.
All market data pertains to the global market at the manufacturers' level.
Data are expressed in current U.S. dollars. The base year of the report is
2011, with historical data provided for 2008 through 2010, and forecast data
provided for 2012 and 2016. Historical, base year and forecast data are
provided for each market segment of the report. Competitor market share
estimates are provided for each market segment for the 2011 base year.
Although this study provides information on a variety of products used to
treat animals, it does not include a comprehensive list of all products
available.
ANALYST CREDENTIALS
Melissa Elder is an experienced healthcare market analyst specializing in
prescription and over-the-counter pharmaceuticals, medical devices, and
emerging healthcare technologies. Ms. Elder has nearly 20 years of experience
in the healthcare industry, specializing in market research for the past 14
years. This experience has given her substantial insight into pharmaceutical
market analysis. Her work in the medical community, including emergency room
medical training and healthcare information system coordination, has enhanced
her ability to provide insight into many healthcare markets.
Table of Contents
Chapter- 1: INTRODUCTION - Complimentary
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST CREDENTIALS
BCC ON-LINE SERVICES
DISCLAIMER
Chapter- 2: SUMMARY
LEADING PRODUCTS AND MANUFACTURERS
Chapter- 3: INDUSTRY OVERVIEW
ANIMAL ANATOMY AND PHYSIOLOGY
ANIMAL POPULATIONS IN THE UNITED STATES
ANIMAL POPULATIONS BY COUNTRY
COMPANION ANIMAL DISEASES
FOOD ANIMAL DISEASES
ZOONOTIC DISEASES
Chapter- 4: ISSUES AFFECTING THE MARKET
ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS
PROBIOTICS
LEGAL AND REGULATORY ISSUES
ADVANCES IN DRUG DELIVERY
BIOTECHNOLOGY IN ANIMAL HEALTH
TRENDS IN COMPANION PET OWNERSHIP
ANIMAL HEALTH INSURANCE
ANIMAL OBESITY
DEMAND IN THE VETERINARY SERVICE INDUSTRY
ADVANCED MEDICAL PROCEDURES
INTERNATIONAL ISSUES AND TRENDS
Chapter- 5: ANIMAL VACCINES
OVERVIEW
PRODUCT DESCRIPTION
COMPANION ANIMAL VACCINES
FOOD ANIMAL VACCINES
MARKET ANALYSIS AND CONCLUSIONS
Chapter- 6: ANIMAL PHARMACEUTICAL PRODUCTS
OVERVIEW
PRODUCT DESCRIPTION
MARKET ANALYSIS AND CONCLUSIONS
Chapter- 7: ANIMAL FEED ADDITIVES
OVERVIEW
PRODUCT DESCRIPTION
NUTRITIONAL SUPPLEMENTS
VITAMINS AND MINERALS
MARKET ANALYSIS AND CONCLUSION
Chapter- 8: ANIMAL DIAGNOSTICS
OVERVIEW
PRODUCT DESCRIPTION
MARKET ANALYSIS AND CONCLUSION
Chapter- 9: MARKET SUMMARY
TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET ANALYSIS
INDUSTRY PARTICIPANTS BY TYPE
Table 64 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY PRODUCT SEGMENT, THROUGH 2016
Figure 37 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY PRODUCT SEGMENT, 2008-2016
Chapter- 10: COMPANY PROFILES
ABAXIS INC.
AUV VETERINARY COOPERATIVE
BASF ANIMAL NUTRITION (BASF SE)
BAYER ANIMAL HEALTH
BOEHRINGER INGELHEIM CORP.
DSM NUTRITIONAL PRODUCTS LTD.
ELANCO ANIMAL HEALTH
EVONIK INDUSTRIES AG
HESKA CORP.
IDEXX LABORATORIES INC.
MERCK & CO. INC.
MOSAIC CO. (THE)
NOVARTIS ANIMAL HEALTH INC.
NOVUS INTERNATIONAL INC.
PFIZER ANIMAL HEALTH
SANOFI
VIRBAC SA
Chapter- 11: APPENDICES
APPENDIX I: LEADING MANUFACTURES AND AFFILIATED COMPANIES
APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS
List of Tables
Summary Table : TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY MAJOR
SEGMENT, THROUGH 2016
Table 1 : GESTATION PERIODS OF SELECT COMMON SPECIES
Table 2 : LIFESPAN OF COMMON PET AVIAN SPECIES
Table 3 : U.S. HOUSEHOLD STATISTICS FOR COMPANION ANIMALS, 2011
Table 4 : U.S. ESTIMATED POPULATIONS OF COMPANION ANIMALS, 2011
Table 5 : U.S. REPORTED POPULATION OF FOOD PRODUCTION ANIMALS, 2005 AND
2010*
Table 6 : DOG (CANINE) POPULATION BY COUNTRY, 2010
Table 7 : CAT (FELINE) POPULATION BY COUNTRY
Table 8 : HORSE (EQUINE) POPULATION BY COUNTRY
Table 9 : CATTLE (BOVINE) POPULATION BY COUNTRY
Table 10 : PIG/HOG (SWINE) POPULATION BY COUNTRY
Table 11 : SHEEP/LAMB POPULATION BY COUNTRY
Table 12 : GOAT POPULATION BY COUNTRY
Table 13 : COUNTRIES WITH THE HIGHEST REPORTED ANIMAL POPULATIONS
Table 14 : COMMON EXAMPLES OF ZOONOTIC DISEASES
Table 15 : CURRENT LIST OF APPROVED ANTIBIOTICS/ANTIMICROBIALS USED IN
FOOD-PRODUCING ANIMALS IN THE UNITED STATES
Table 16 : ANTIMICROBIAL DRUG USE AND SALES IN FOOD-PRODUCING ANIMALS, 2010
Table 17 : APPA NATIONAL PET OWNERS SURVEY, 2011-2012 BASIC ANNUAL
EXPENSES FOR DOGS AND CATS
Table 18 : DOG INSURANCE PLAN COMPARISONS, UNITED STATES
Table 19 : CAT INSURANCE PLAN COMPARISONS, UNITED STATES
Table 20 : ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN THE UNITED STATES
BY TYPE OF PRACTICE, 2011
Table 21 : ESTIMATED NUMBER OF VETERINARIAN'S IN THE UNITED STATES BY
YEAR, 2007 - 2011
Table 22 : ESTIMATED POPULATIONS OF COMPANION ANIMALS IN JAPAN AND
AUSTRALIA, 2010
Table 23 : ESTIMATED POPULATIONS OF FARM ANIMALS IN ARGENTINA, BRAZIL AND
INDIA, 2010
Table 24 : VACCINES BY TARGET SPECIES AND PROVIDERS
Table 25 : MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, THROUGH 2016
Table 26 : ESTIMATED REVENUES FOR ANIMAL VACCINES BY TYPE, THROUGH 2016
Table 27 : DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION,
2011
Table 28 : COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE,
2011
Table 29 : ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES AND PROVIDERS
Table 30 : ANTI-INFECTIVES BY TARGET SPECIES AND PROVIDERS
Table 31 : ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES AND
PROVIDERS
Table 32 : METABOLIC DRUGS BY TARGET SPECIES AND PROVIDERS
Table 33 : PARASITICIDES BY TARGET SPECIES AND PROVIDERS
Table 34 : OTHER PHARMACEUTICALS BY TARGET SPECIES AND PROVIDERS
Table 35 : MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE,
THROUGH 2016
Table 36 : MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, THROUGH 2016
Table 37 : MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE,
THROUGH 2016
Table 38 : MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, THROUGH 2016
Table 39 : MARKET ANALYSIS FOR PARASITICIDES BY USE, THROUGH 2016
Table 40 : MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, THROUGH 2016
Table 41 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE,
THROUGH 2016
Table 42 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE,
THROUGH 2016
Table 43 : DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD
REGION, 2011
Table 44 : COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY
COMPETITOR REVENUES, 2011
Table 45 : AMINO ACIDS BY TARGET SPECIES AND PROVIDERS
Table 46 : MEDICINAL ADDITIVES BY TARGET SPECIES AND PROVIDERS
Table 47 : NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES AND PROVIDERS
Table 48 : VITAMINS AND MINERALS BY TARGET SPECIES AND PROVIDERS
Table 49 : MARKET ANALYSIS FOR AMINO ACIDS BY USE, THROUGH 2016
Table 50 : MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, THROUGH
2016
Table 51 : MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, THROUGH 2016
Table 52 : MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, THROUGH 2016
Table 53 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, THROUGH 2016
Table 54 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE,
THROUGH 2016
Table 55 : DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD
REGION, 2011
Table 56 : COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR
REVENUES, 2011
Table 57 : DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS
Table 58 : MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE, THROUGH
2016
Table 59 : REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2016
Table 60 : REVENUES FOR RAPID DIAGNOSTICS BY TYPE (VETERINARY
APPLICATIONS), THROUGH 2016
Table 61 : REVENUES FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TYPE
(VETERINARY APPLICATIONS), THROUGH 2016
Table 62 : DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD
REGION, 2011
Table 63 : COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR
REVENUES, 2011
Table 64 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY PRODUCT SEGMENT, THROUGH 2016
Table 65 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY ANIMAL TYPE, THROUGH 2016
Table 66 : DISTRIBUTION OF REVENUES FOR ANIMAL THERPEUTICS AND DIAGNOSTICS
BY WORLD REGION, 2011
Table 67 : MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE
Table 68 : TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL THERAPEUTICS AND
DIAGNOSTICS BY MANUFACTURER REVENUES, 2011
Table 69 : COMPETITOR MARKET POSITION - ANIMAL THERAPEUTICS AND
DIAGNOSTICS BY MANUFACTURER REVENUES, 2011
List of Figures
Summary Figure : TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY MAJOR
SEGMENT, 2008-2016
Figure 1 : DOG (CANINE) POPULATION - TOP 10 COUNTRIES, 2010
Figure 2 : CAT (FELINE) POPULATION - TOP 10 COUNTRIES, 2010
Figure 3 : HORSE (EQUINE) POPULATION - TOP 10 COUNTRIES, 2010
Figure 4 : CATTLE (BOVINE) POPULATION - TOP 10 COUNTRIES, 2010
Figure 5 : PIG/HOG (SWINE) POPULATION - TOP 10 COUNTRIES, 2010
Figure 6 : SHEEP/LAMB POPULATION - TOP 10 COUNTRIES, 2010
Figure 7 : GOAT POPULATION - TOP 10 COUNTRIES, 2010
Figure 8 : ESTIMATED NUMBER OF VETERINARIAN'S IN THE UNITED STATES BY
YEAR, 2007-2011
Figure 9 : MARKET ANALYSIS FOR ANIMAL VACCINES BY USE, 2008-2016
Figure 10 : ESTIMATED REVENUES FOR ANIMAL VACCINES BY TYPE, 2008-2016
Figure 11 : DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES BY WORLD REGION,
2011
Figure 12 : COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY COMPETITOR REVENUE,
2011
Figure 13 : MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY PRODUCTS BY USE,
2008-2016
Figure 14 : MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE, 2008-2016
Figure 15 : MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND ANALGESICS BY USE,
2008-2016
Figure 16 : MARKET ANALYSIS FOR METABOLIC DRUGS BY USE, 2008-2016
Figure 17 : MARKET ANALYSIS FOR PARASITICIDES BY USE, 2008-2016
Figure 18 : MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY USE, 2008-2016
Figure 19 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY USE,
2008-2016
Figure 20 : MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE,
2008-2016
Figure 21 : DISTRIBUTION OF REVENUES FOR ANIMAL PHARMACEUTICALS BY WORLD
REGION, 2011
Figure 22 : COMPETITIVE SUMMARY FOR ANIMAL PHARMACEUTICAL PRODUCTS BY
COMPETITOR REVENUES, 2011
Figure 23 : MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2008-2016
Figure 24 : MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES BY USE, 2008-2016
Figure 25 : MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS BY USE, 2008-2016
Figure 26 : MARKET ANALYSIS FOR VITAMINS AND MINERALS BY USE, 2008-2016
Figure 27 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY USE, 2008-2016
Figure 28 : MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE,
2008-2016
Figure 29 : DISTRIBUTION OF REVENUES FOR ANIMAL FEED ADDITIVES BY WORLD
REGION, 2011
Figure 30 : COMPETITIVE SUMMARY FOR ANIMAL FEED ADDITIVES BY COMPETITOR
REVENUES, 2011
Figure 31 : MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS PRODUCTS BY USE,
2008-2016
Figure 32 : REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2008-2016
Figure 33 : REVENUES FOR RAPID DIAGNOSTICS BY TYPE (VETERINARY
APPLICATIONS), 2008-2016
Figure 34 : REVENUES FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TYPE
(VETERINARY APPLICATIONS), 2008-2016
Figure 35 : DISTRIBUTION OF REVENUES FOR ANIMAL DIAGNOSTICS BY WORLD
REGION, 2011
Figure 36 : COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS BY COMPETITOR
REVENUES, 2011
Figure 37 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY PRODUCT SEGMENT, 2008-2016
Figure 38 : TOTAL MARKET ANALYSIS FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS
BY ANIMAL TYPE, 2008-2016
Figure 39 : DISTRIBUTION OF REVENUES FOR ANIMAL THERAPEUTICS AND
DIAGNOSTICS BY WORLD REGION, 2011
Figure 40 : TOTAL COMPETITIVE SUMMARY FOR ANIMAL THERAPEUTICS AND
DIAGNOSTICS BY COMPETITOR REVENUES, 2011
